Alto Neuroscience (ANRO) Assets Average (2024 - 2026)

Alto Neuroscience has disclosed Assets Average across 3 years of filings, most recently posting $230.5 million for Q1 2026.

• Assets Average for Q1 2026 came in at $230.5 million, up 31.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $230.5 million (up 31.9% YoY), and the FY2025 annual result was $181.1 million, up 37.12% from the prior year.
• Assets Average came in at $230.5 million for Q1 2026 at Alto Neuroscience, up from $165.8 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $230.5 million in Q1 2026 to a low of $148.3 million in Q1 2024.
• The 3-year median for Assets Average is $174.7 million (2025), against an average of $179.9 million.
• Across the five-year window, Assets Average dropped 21.62% in 2025 and jumped 31.9% in 2026, its largest moves.
• Alto Neuroscience's Assets Average stood at $184.6 million in 2024, then fell by 10.15% to $165.8 million in 2025, then jumped by 38.97% to $230.5 million in 2026.
• The last three Assets Average figures came in at $230.5 million (Q1 2026), $165.8 million (Q4 2025), and $152.4 million (Q3 2025), per Business Quant data.